Company Filing History:
Years Active: 2024
Title: Vyjayanthi Krishnan: Innovator in Therapeutic Regimens
Introduction
Vyjayanthi Krishnan is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of therapeutic regimens, particularly in the management of blood glucose and body weight. His innovative work has the potential to impact the lives of many individuals struggling with obesity and related health issues.
Latest Patents
Krishnan holds a patent for "Therapeutic regimens and methods for lowering blood glucose and/or body weight using GLP-1R and GCGR balanced agonists." This patent relates to a once-weekly dosing regimen of a dual GLP-1R and GCGR agonist, along with formulations and methods for treating chronic weight management, obesity, and blood glucose control. The patent includes a dual agonist peptide product of SEQ ID NO. 1, showcasing his innovative approach to addressing these health challenges.
Career Highlights
Currently, Vyjayanthi Krishnan is associated with Spitfire Pharma, Inc., where he continues to develop and refine his therapeutic innovations. His work at Spitfire Pharma emphasizes the importance of research and development in creating effective treatment options for patients.
Collaborations
Krishnan collaborates with talented professionals in his field, including Joyce James and Omar Roble Olhaye. These collaborations enhance the research and development process, fostering an environment of innovation and creativity.
Conclusion
Vyjayanthi Krishnan's contributions to therapeutic regimens highlight his commitment to improving health outcomes through innovative solutions. His work in developing methods for managing blood glucose and body weight is a testament to the impact of dedicated inventors in the medical field.